Enlacard (5 mg) (Enalapril) Drug Price and Information
Enalapril (Enlacard (5 mg)) is an ACE (angiotensin-converting enzyme) inhibitor, prescribed for high blood pressure either alone or with other medications. It is also used for heart failure. It decreases certain chemicals that tighten the blood vessels.
The recommended dose is 2.5 mg to 20mg per day, once or twice daily.
Side effects of Enlacard (5 mg)
Body As A Whole : Fainting, chest pain, fatigue, abdominal pain and weakness.
Heart : Low blood pressure, chest pain and heart attack.
Gastrointestinal : Diarrhea, nausea and vomiting.
Central nervous System Dizziness and headache.
Respiratory Cough, asthma and difficulty in breathing.
Genitourinary Urinary tract infection.
How to use Enlacard (5 mg)?
It comes as a tablet to take by mouth, with or without food.
When Should Enlacard (5 mg) not be taken? (Contraindications)
Contraindicated in patients with history of angioedema due to previous treatment with ACE inhibitors, pregnancy, newborns and hypersensitivity.
Warnings and Precautions for Enlacard (5 mg)
Caution should be exercised in patients with history of heart or kidney disease, skin disorder, diabetes, cardiac muscle disease, poor blood circulation, dehydration, dialysis, any allergy, who are taking other medications, during pregnancy and breastfeeding.
It may cause dizziness or lightheadedness, do not drive a car or operate machinery while taking this medication.
It may cause vomiting or diarrhea which leads to dehydration; take enough fluids to avoid this problem.
Avoid exposure to sunlight; otherwise it may cause sunburn.
Patient may develop with increased risk of Dual Blockade of Renin-Angiotensin System (RAS).
Other Precautions for Enlacard (5 mg)
Monitor liver function, kidney function and complete blood cell counts regularly while taking this medication.
Storage Conditions for Enlacard (5 mg)
Store it at room temperature and protect it from moisture.
Schedule : H Prescription drugs - Drugs to be sold only under the prescription of a Registered Medical Practitioner.
Enalapril (Renitec): Drug Treats High Blood Pressure, Diabetic Kidney Disease, and Heart Failure
Q: Is it safe to take Enlacard (5 mg) for a long time?
A: Yes, since most people tolerate Enlacard (5 mg) well, it can be taken for a long time. However, long-term use can have an impact on kidney function (2✔✔Trusted Source Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure
Q: Is Enlacard (5 mg) safe to use in diabetic patients?
A: Enlacard (5 mg) may alter your blood sugar levels and mask the symptoms of low blood sugar. As a precaution, you should inform your doctor if you have diabetes before taking this medication (4✔✔Trusted Source Metabolic effects of hydrochlorothiazide and enalapril during treatment of the hypertensive diabetic patient. Enalapril for hypertensive diabetics
4. Metabolic effects of hydrochlorothiazide and enalapril during treatment of the hypertensive diabetic patient. Enalapril for hypertensive diabetics - (https://pubmed.ncbi.nlm.nih.gov/2847668/ )
Search for Drugs/Medicines
Medindia updates the prices regularly, however, there may be slight discrepancies in the prices displayed. This can be due to the following reasons:Medindia updates the prices regularly, however, there may be slight discrepancies in the prices displayed. This can be due to the following reasons:
Difference in GST/local taxes
Change in price by the company
Updation of price information may not have happened at the right time
For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does not intend to replace professional medical opinion in any manner whatsoever. Please also be aware that Medindia does not buy or sell medication.
Post a Comment
Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.